University of Illinois at Chicago (Site 008-012) — Chicago, Illinois

University of Illinois at Chicago (Site 008-012) is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Illinois at Chicago (Site 008-012) has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: COVID-19, Infectious Disease.

Sponsors: University of Minnesota.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Illinois at Chicago (Site 008-012)?

University of Illinois at Chicago (Site 008-012) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Illinois at Chicago (Site 008-012) conducted?

University of Illinois at Chicago (Site 008-012) has 2 clinical trials on record, with 1 currently active. Their work covers COVID-19, Infectious Disease.

Is University of Illinois at Chicago (Site 008-012) accredited by Crixeo Health?

University of Illinois at Chicago (Site 008-012) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Illinois at Chicago (Site 008-012)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.